Form 8-K - Current report:
SEC Accession No. 0001104659-23-128217
Filing Date
2023-12-21
Accepted
2023-12-21 16:15:19
Documents
12
Period of Report
2023-12-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2333499d1_8k.htm   iXBRL 8-K 26142
  Complete submission text file 0001104659-23-128217.txt   199050

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ispc-20231215.xsd EX-101.SCH 3018
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ispc-20231215_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ispc-20231215_pre.xml EX-101.PRE 22361
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2333499d1_8k_htm.xml XML 3348
Mailing Address 450 BEDFORD STREET SUITE 1010 LEXINGTON MA 02420
Business Address 450 BEDFORD STREET SUITE 1010 LEXINGTON MA 02420 781-301-6700
iSpecimen Inc. (Filer) CIK: 0001558569 (see all company filings)

EIN.: 270480143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40501 | Film No.: 231505459
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)